Northwest Investment Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-350
Closed -$26.7K 596
2023
Q1
$26.7K Buy
+350
New +$29K 0.01% 298

Other funds holding XBI

Northwest Investment Counselors's XBI Position: Q2 2023 in Review

Northwest Investment Counselors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 350 shares — an estimated $26.7K sold.

Northwest Investment Counselors first reported a position in XBI in Q1 2023 and held it in 1 quarter. The position peaked at $26.7K in Q1 2023. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

  • Northwest Investment Counselors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
  • Northwest Investment Counselors sold 350 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $26.7K.
  • Northwest Investment Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 1 quarter.
  • Northwest Investment Counselors's State Street SPDR S&P Biotech ETF position peaked at $26.7K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Northwest Investment Counselors's 13F filing for Q2 2023, filed 11 Jul 2023.